KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · IEX Real-Time Price · USD
11.21
-0.23 (-2.01%)
At close: Apr 23, 2024, 4:00 PM
11.25
+0.04 (0.36%)
After-hours: Apr 23, 2024, 7:35 PM EDT
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $472.93 million as of April 23, 2024. Its market cap has increased by 74.97% in one year.
Market Cap
472.93M
Enterprise Value
403.60M
1-Year Change
74.97%
Ranking
Category
Stock Price
$11.21
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $472.93M, an increase of 265.76%. That is a compound annual growth rate of 15.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2024 | 482.60M | -1.13% |
| Apr 19, 2024 | 488.10M | 0.60% |
| Apr 18, 2024 | 485.20M | -1.28% |
| Apr 17, 2024 | 491.50M | -1.94% |
| Apr 16, 2024 | 501.20M | 1.19% |
| Apr 15, 2024 | 495.30M | -1.26% |
| Apr 12, 2024 | 501.60M | -1.74% |
| Apr 11, 2024 | 510.50M | 1.43% |
| Apr 10, 2024 | 503.30M | 1.02% |
| Apr 9, 2024 | 498.20M | 6.96% |
| Apr 8, 2024 | 465.80M | -0.45% |
| Apr 5, 2024 | 467.90M | -1.06% |
| Apr 4, 2024 | 472.90M | -0.44% |
| Apr 3, 2024 | 475.00M | 1.98% |
| Apr 2, 2024 | 465.80M | -3.14% |
| Apr 1, 2024 | 480.90M | -3.90% |
| Mar 28, 2024 | 500.40M | 7.15% |
| Mar 27, 2024 | 467.00M | -0.36% |
| Mar 26, 2024 | 468.70M | -0.19% |
| Mar 25, 2024 | 469.60M | -6.06% |
| Mar 22, 2024 | 499.90M | -2.48% |
| Mar 21, 2024 | 512.60M | -0.66% |
| Mar 20, 2024 | 516.00M | 3.30% |
| Mar 19, 2024 | 499.50M | -1.25% |
| Mar 18, 2024 | 505.80M | 0.50% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Applied Therapeutics | 503.81M |
| Alector | 495.02M |
| UroGen Pharma | 490.33M |
| Orthofix Medical | 489.28M |
| Calliditas Therapeutics AB (publ) | 485.26M |
| PetIQ | 481.89M |
| Annexon | 477.62M |
| Arbutus Biopharma | 475.66M |